- Home
- Publications
- Publication Search
- Publication Details
Title
Role of STAT3 signaling pathway in breast cancer
Authors
Keywords
-
Journal
Cell Communication and Signaling
Volume 18, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-02-29
DOI
10.1186/s12964-020-0527-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Therapeutic impact of Nintedanib with paclitaxel and/or a PD-L1 antibody in preclinical models of orthotopic primary or metastatic triple negative breast cancer
- (2019) Elaine Reguera-Nuñez et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- RER1 enhances carcinogenesis and stemness of pancreatic cancer under hypoxic environment
- (2019) Shi Chen et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Depletion of RIPK1 in hepatocytes exacerbates liver damage in fulminant viral hepatitis
- (2019) Muhammad Farooq et al. Cell Death & Disease
- SP1 and STAT3 Functionally Synergize to Induce the RhoU Small GTPase and a Subclass of Non-canonical WNT Responsive Genes Correlating with Poor Prognosis in Breast Cancer
- (2019) Emanuele Monteleone et al. Cancers
- The Expression Patterns of FAM83H and PANX2 Are Associated With Shorter Survival of Clear Cell Renal Cell Carcinoma Patients
- (2019) Kyoung Min Kim et al. Frontiers in Oncology
- Tumor-Associated Macrophages Induce Endocrine Therapy Resistance in ER+ Breast Cancer Cells
- (2019) Andrés M. Castellaro et al. Cancers
- 15-Keto prostaglandin E2 suppresses STAT3 signaling and inhibits breast cancer cell growth and progression
- (2019) Eun Ji Lee et al. Redox Biology
- Dihydrotanshinone-Induced NOX5 Activation Inhibits Breast Cancer Stem Cell through the ROS/Stat3 Signaling Pathway
- (2019) Su-Lim Kim et al. Oxidative Medicine and Cellular Longevity
- TGFβ promotes breast cancer stem cell self-renewal through an ILEI/LIFR signaling axis
- (2019) Alec N. Woosley et al. ONCOGENE
- Cell Permeable NBD Peptide-Modified Liposomes by Hyaluronic Acid Coating for the Synergistic Targeted Therapy of Metastatic Inflammatory Breast Cancer
- (2019) Yuqing Sun et al. MOLECULAR PHARMACEUTICS
- Combined inhibition of STAT3 and DNA repair in palbociclib-resistant ER-positive breast cancer
- (2019) Nicole M. Kettner et al. CLINICAL CANCER RESEARCH
- MEST induces Twist-1-mediated EMT through STAT3 activation in breast cancers
- (2019) Min Soo Kim et al. CELL DEATH AND DIFFERENTIATION
- Bazedoxifene is a novel IL-6/GP130 inhibitor for treating triple-negative breast cancer
- (2019) Jilai Tian et al. BREAST CANCER RESEARCH AND TREATMENT
- Inflammatory Breast Cancer Promotes Development of M2 Tumor-associated Macrophages and Cancer Mesenchymal Cells Through a Complex Cytokine Network
- (2019) Amanda Valeta-Magara et al. CANCER RESEARCH
- Interleukin-32θ inhibits tumor-promoting effects of macrophage-secreted CCL18 in breast cancer
- (2019) Thu-Huyen Pham et al. Cell Communication and Signaling
- The effects of PTPN2 loss on cell signalling and clinical outcome in relation to breast cancer subtype
- (2019) Cynthia Veenstra et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Epigenetic inhibition of the tumor suppressor ARHI by light at night‐induced circadian melatonin disruption mediates STAT 3‐driven paclitaxel resistance in breast cancer
- (2019) Shulin Xiang et al. JOURNAL OF PINEAL RESEARCH
- PIM1 is responsible for IL-6-induced breast cancer cell EMT and stemness via c-myc activation
- (2019) Xueqiang Gao et al. Breast Cancer
- Downregulation of DPF3 promotes the proliferation and motility of breast cancer cells through activating JAK2/STAT3 signaling
- (2019) Wei-hao Lin et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Metformin reverses mesenchymal phenotype of primary breast cancer cells through STAT3/NF-κB pathways
- (2019) José Esparza-López et al. BMC CANCER
- A mutual activation loop between the Ca2+-activated chloride channel TMEM16A and EGFR/STAT3 signaling promotes breast cancer tumorigenesis
- (2019) Hui Wang et al. CANCER LETTERS
- MiR-124 reversed the doxorubicin resistance of breast cancer stem cells through STAT3/HIF-1 signaling pathways
- (2019) Cong Liu et al. CELL CYCLE
- Discovery of fluorescent coumarin-benzo[b]thiophene 1, 1-dioxide conjugates as mitochondria-targeting antitumor STAT3 inhibitors
- (2019) Guiping Cai et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Ilamycin C induces apoptosis and inhibits migration and invasion in triple-negative breast cancer by suppressing IL-6/STAT3 pathway
- (2019) Qing Xie et al. Journal of Hematology & Oncology
- TARGETING MUC1-C INHIBITS TWIST1 SIGNALING IN TRIPLE-NEGATIVE BREAST CANCER
- (2019) Tsuyoshi Hata et al. MOLECULAR CANCER THERAPEUTICS
- Progranulin sustains STAT 3 hyper‐activation and oncogenic function in colorectal cancer cells
- (2019) Federica Laudisi et al. Molecular Oncology
- Identification of novel inhibitors of signal transducer and activator of transcription 3 over signal transducer and activator of transcription 1 for the treatment of breast cancer by in-silico and in-vitro approach
- (2019) Stella Sravanthi V. et al. PROCESS BIOCHEMISTRY
- A Sesquiterpenoid from Farfarae Flos Induces Apoptosis of MDA-MB-231 Human Breast Cancer Cells through Inhibition of JAK–STAT3 Signaling
- (2019) Hyeri Jang et al. Biomolecules
- Novel Galiellalactone Analogues Can Target STAT3 Phosphorylation and Cause Apoptosis in Triple-Negative Breast Cancer
- (2019) Hyejin Ko et al. Biomolecules
- Bayesian Inference Identifies Combination Therapeutic Targets in Breast Cancer
- (2019) Haswanth Vundavilli et al. IEEE TRANSACTIONS ON BIOMEDICAL ENGINEERING
- STAT3 Targets ERR-α to Promote Epithelial–Mesenchymal Transition, Migration, and Invasion in Triple-Negative Breast Cancer Cells
- (2019) Jia-Hui Ma et al. MOLECULAR CANCER RESEARCH
- The COOH-Terminal Proline-Rich Region of GRP78 Is a Key Regulator of Its Cell Surface Expression and Viability of Tamoxifen-Resistant Breast Cancer Cells
- (2019) Chun-Chih Tseng et al. NEOPLASIA
- CDK5RAP3 is a co-factor for the oncogenic transcription factor STAT3
- (2019) Susana P. Egusquiaguirre et al. NEOPLASIA
- Isoharringtonine inhibits breast cancer stem-like properties and STAT3 signaling
- (2018) Wei Chen et al. BIOMEDICINE & PHARMACOTHERAPY
- C-Phycocyanin exerts anti-cancer effects via the MAPK signaling pathway in MDA-MB-231 cells
- (2018) Liangqian Jiang et al. Cancer Cell International
- Sabutoclax, pan-active BCL-2 protein family antagonist, overcomes drug resistance and eliminates cancer stem cells in breast cancer
- (2018) Yunhui Hu et al. CANCER LETTERS
- JAK/STAT3-Regulated Fatty Acid β-Oxidation Is Critical for Breast Cancer Stem Cell Self-Renewal and Chemoresistance
- (2018) Tianyi Wang et al. Cell Metabolism
- IL-17 inhibits the accumulation of myeloid-derived suppressor cells in breast cancer via activating STAT3
- (2018) Min Ma et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Flubendazole elicits anti-metastatic effects in triple-negative breast cancer via STAT3 inhibition
- (2018) Eunhye Oh et al. INTERNATIONAL JOURNAL OF CANCER
- microRNA-30d mediated breast cancer invasion, migration, and EMT by targeting KLF11 and activating STAT3 pathway
- (2018) Mingli Han et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Napabucasin and Related Heterocycle-Fused Naphthoquinones as STAT3 Inhibitors with Antiproliferative Activity against Cancer Cells
- (2018) Hauke Löcken et al. JOURNAL OF NATURAL PRODUCTS
- Catechol derived from aronia juice through lactic acid bacteria fermentation inhibits breast cancer stem cell formation via modulation Stat3/IL-6 signaling pathway
- (2018) Hack S. Choi et al. MOLECULAR CARCINOGENESIS
- Activation of STAT3 and Bcl-2 and reduction of reactive oxygen species (ROS) promote radioresistance in breast cancer and overcome of radioresistance with niclosamide
- (2018) Lu Lu et al. ONCOGENE
- Histone deacetylase 6 regulates the immunosuppressive properties of cancer-associated fibroblasts in breast cancer through the STAT3–COX2-dependent pathway
- (2018) Ang Li et al. ONCOGENE
- TRIM14 promotes breast cancer cell proliferation by inhibiting apoptosis
- (2018) Gaowu Hu et al. ONCOLOGY RESEARCH
- Lapatinib Inhibits Breast Cancer Cell Proliferation by Influencing PKM2 Expression
- (2018) Mingxiu Guan et al. TECHNOLOGY IN CANCER RESEARCH & TREATMENT
- miRNA-3473b contributes to neuroinflammation following cerebral ischemia
- (2018) Xiaoyu Wang et al. Cell Death & Disease
- Plumbagin inhibits the proliferation and survival of esophageal cancer cells by blocking STAT3-PLK1-AKT signaling
- (2018) Ying-Ya Cao et al. Cell Death & Disease
- Network connectivity determines cortical thinning in early Parkinson’s disease progression
- (2018) Y. Yau et al. Nature Communications
- Assessment of Polysaccharides from Mycelia of genus Ganoderma by Mid-Infrared and Near-Infrared Spectroscopy
- (2018) Yuhan Ma et al. Scientific Reports
- The STAT3 Target Gene TNFRSF1A Modulates the NF-κB Pathway in Breast Cancer Cells
- (2018) Susana P. Egusquiaguirre et al. NEOPLASIA
- Tagalide A and tagalol A, naturally occurring 5/6/6/6- and 5/6/6-fused cyclic dolabrane-type diterpenes: a new insight into the anti-breast cancer activity of the dolabrane scaffold
- (2018) Xiao-Hui Zhang et al. Organic Chemistry Frontiers
- Interleukin-22 promotes triple negative breast cancer cells migration and paclitaxel resistance through JAK-STAT3/MAPKs/AKT signaling pathways
- (2018) Shuqian Wang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- STAT3 activation confers trastuzumab-emtansine (T-DM1) resistance in HER2-positive breast cancer
- (2018) Lei Wang et al. CANCER SCIENCE
- Long noncoding RNA H19 competitively binds miR-93-5p to regulate STAT3 expression in breast cancer
- (2018) Jia-Peng Li et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Esculentoside A suppresses breast cancer stem cell growth through stemness attenuation and apoptosis induction by blocking IL-6/STAT3 signaling pathway
- (2018) Chuanlan Liu et al. PHYTOTHERAPY RESEARCH
- Sesquiterpene lactones-enriched fraction of Inula helenium L. induces apoptosis through inhibition of signal transducers and activators of transcription 3 signaling pathway in MDA-MB-231 breast cancer cells
- (2018) Jaemoo Chun et al. PHYTOTHERAPY RESEARCH
- Cyanidin-3-glucoside attenuates the angiogenesis of breast cancer via inhibiting STAT3/VEGF pathway
- (2018) Xiao Ma et al. PHYTOTHERAPY RESEARCH
- Adjuvant therapy with stattic enriches the anti-proliferative effect of doxorubicin in human ZR-75-1 breast cancer cells via arresting cell cycle and inducing apoptosis
- (2018) Fatemeh khaki-khatibi et al. BIOMEDICINE & PHARMACOTHERAPY
- Breast cancer cell–derived IL-35 promotes tumor progression via induction of IL-35-producing induced regulatory T cells
- (2018) Shengnan Hao et al. CARCINOGENESIS
- PKM2 promotes glucose metabolism through a let-7a-5p/Stat3/hnRNP-A1 regulatory feedback loop in breast cancer cells
- (2018) Ao Yao et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Chlorogenic acid inhibits osteosarcoma carcinogenesis via suppressing the STAT3/Snail pathway
- (2018) Fang Zhang et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- The role of DEAD-box RNA helicase p68 (DDX5) in the development and treatment of breast cancer
- (2018) Vida Hashemi et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Osthole inhibits triple negative breast cancer cells by suppressing STAT3
- (2018) Xuanxuan Dai et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- DT-13 suppresses breast cancer metastasis by modulating PLOD2 in the adipocytes microenvironment
- (2018) Jinyong He et al. PHYTOMEDICINE
- Methylseleninic Acid Suppresses Breast Cancer Growth via the JAK2/STAT3 Pathway
- (2018) Changwei Qiu et al. Reproductive Sciences
- Overexpression of MicroRNA-9 inhibits proliferation of human breast cancer cells by targeting STAT3
- (2018) Yan Zhang et al. TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH
- Rho GTPase Activating Protein 24 (ARHGAP24) Regulates the Anti-Cancer Activity of Sorafenib Against Breast Cancer MDA-MB-231 Cells via the Signal Transducer and Activator of Transcription 3 (STAT3) Signaling Pathway
- (2018) Xianping Dai et al. MEDICAL SCIENCE MONITOR
- Kinome-Wide siRNA Screening Identifies Src-Enhanced Resistance of Chemotherapeutic Drugs in Triple-Negative Breast Cancer Cells
- (2018) Yen-Dun Tony Tzeng et al. Frontiers in Pharmacology
- Co-Expression of VEGF and IL-6 Family Cytokines is Associated with Decreased Survival in HER2 Negative Breast Cancer Patients: Subtype-Specific IL-6 Family Cytokine-Mediated VEGF Secretion
- (2018) Ken Tawara et al. Translational Oncology
- Scorpion Venom Causes Upregulation of p53 and Downregulation of Bcl-xL and BID Protein Expression by Modulating Signaling Proteins Erk1/2 and STAT3, and DNA Damage in Breast and Colorectal Cancer Cell Lines
- (2017) Abdulrahman Khazim Al-Asmari et al. INTEGRATIVE CANCER THERAPIES
- Precise discovery of a STAT3 inhibitor from Eupatorium lindleyanum and evaluation of its activity of anti-triple-negative breast cancer
- (2017) Bo Yang et al. NATURAL PRODUCT RESEARCH
- Schisandrin A reverses doxorubicin-resistant human breast cancer cell line by the inhibition of P65 and Stat3 phosphorylation
- (2017) Zong-Lin Zhang et al. Breast Cancer
- Strategies and Approaches of Targeting STAT3 for Cancer Treatment
- (2016) Steffanie L. Furtek et al. ACS Chemical Biology
- The IL-6/gp130/STAT3 signaling axis: recent advances towards specific inhibition
- (2015) Christoph Garbers et al. CURRENT OPINION IN IMMUNOLOGY
- Role of STAT3 in Cancer Metastasis and Translational Advances
- (2013) Mohammad Zahid Kamran et al. Biomed Research International
- GP88 (PC-Cell Derived Growth Factor, progranulin) stimulates proliferation and confers letrozole resistance to aromatase overexpressing breast cancer cells
- (2011) Tesfom Abrhale et al. BMC CANCER
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started